Laurus Labs’ stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The company is investing ₹3,000 crore in expanding capacities, particularly for high-value CDMO services, which are projected to double their revenue share by 2030. Analysts are optimistic, raising earnings forecasts and maintaining a ‘BUY’ rating, anticipating continued growth across its diverse segments.
Boeing shares rise 5% despite higher than expected Q2 loss on Air Force One costs
Boeing posted a wider-than-expected Q2 loss after a $280 million Air Force One charge, but shares rose 5% as positive free cash flow and higher
July 28, 2026